Raleigh, NC, United States of America

David Katz

This inventor holds 1 USPTO granted patent. Top assignee: Duke University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Katz. Retrieved from https://idiyas.com/inventor/david-katz-3mmx192n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Katz: Innovator in Cancer Treatment

Introduction

David Katz is a notable inventor based in Raleigh, NC (US), recognized for his contributions to medical technology, particularly in the field of cancer treatment. His innovative approach focuses on methods for treating various types of lesions, including cancerous and benign ones.

Latest Patents

Katz holds a patent titled "Methods for the treatment of cancer and benign lesions by ablation." This patent outlines a method for treating lesions by administering a therapy solution that includes a viscous carrier and an alcohol or hydrophobic anti-cancer agent. The solution is designed to effectively treat lesions, with specific embodiments detailing the use of an ethyl cellulose-ethanol mixture and administration rates ranging from about 1 mL/hr to about 15 mL/hr.

Career Highlights

David Katz is affiliated with Duke University, where he continues to advance research in cancer treatment methodologies. His work has the potential to significantly impact the medical field by providing new avenues for lesion treatment.

Collaborations

Katz collaborates with esteemed colleagues, including Robert Morhard and Nirmala Ramanujam, who contribute to his research efforts and innovations in the field.

Conclusion

David Katz's work exemplifies the intersection of innovation and healthcare, showcasing how inventive methods can lead to improved treatment options for patients. His contributions are vital in the ongoing fight against cancer and benign lesions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…